Viking Therapeutics (VKTX) Return on Assets (QoQ) (2015 - 2026)

Viking Therapeutics (VKTX) Return on Assets (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Viking Therapeutics 4.09 Bn 4.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 24.00
Jun 30, 2024 85.00
Mar 31, 2024 245.00
Dec 31, 2023 -15.00
Sep 30, 2023 58.00
Jun 30, 2023 -21.00
Mar 31, 2023 -378.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 2.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00